THE ROLE OF GUT MICROBIOTA ALTERATIONS IN THE DEVELOPMENT OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS

Authors

  • Ismoilova Robiyaxon Shuxrat qizi Master’s Student of the Department of “Internal Diseases in Family Medicine,” Specialty “Therapy,” CAMU International Medical University
  • Kenjayev Olimjon Obidjonovich Ph.D., Head of the Department of “Internal Diseases in Family Medicine,” CAMU International Medical University

Keywords:

liver cirrhosis, gut microbiota, dysbiosis, gut–liver axis, metabolic disorders, toxic metabolites, opportunistic bacteria, liver function, microecology

Abstract

This article is devoted to the study of structural changes in the gut microbiota of patients with liver cirrhosis and their impact on the course of the disease. During the progression of liver cirrhosis, disruption of the intestinal microecological balance may lead to alterations in metabolic processes and further deterioration of liver function. In this article, qualitative and quantitative changes in the gut microbiota were analyzed. The findings demonstrated that dysbiosis, characterized by a reduction in beneficial bacteria and an increase in certain opportunistic microorganisms, is widespread among patients with liver cirrhosis. Such alterations in the gut microbiota may contribute to dysfunction of the gut–liver axis and create conditions for the accumulation of toxic metabolites in the body. Furthermore, changes in microbiota composition were found to be associated with the clinical course and severity of the disease. The conclusions obtained indicate that the assessment of gut microbiota is of significant importance in determining the developmental characteristics of liver cirrhosis. The study findings provide a scientific basis for improving preventive and therapeutic approaches aimed at restoring intestinal microecology.

References

Ouyang Li 1 2, Han Xu 1 3, Dayoung Kim 1 3, Fan Yang 1 3, Zhijun Bao 1 2 3

Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai, China

Department of Gastroenterology, Huadong Hospital Affiliated to Fudan University, Shanghai, China

Department of Gerontology, Huadong Hospital Affiliated to Fudan University, Shanghai, China

Received 9 August 2023, Revised 26 October 2023, Accepted 3 November 2023, Available online 19 November 2023, Version of Record 10 January 2024.

Bajaj JS, et al. Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome. Frontiers in Cellular and Infection Microbiology. 2022.

Study on causal relationship between gut microbiota and hepatic encephalopathy. BMC Medical Genomics. 2024.

Rifaximin’s effects on hepatic encephalopathy and gut microbiota composition. Clinical and Translational Gastroenterology. 2016; Rifaximin, Microbiota Biology, and Hepatic Encephalopathy.

Zhu R, Liu L, Zhang G, et al. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis. Bioscience Reports. 2023.

LE Y, et al. Gut microbiota regulation and diet therapy for hepatic encephalopathy. Journal of Clinica

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. Francesca Romanda Ponziani, Viviana Gerardi, Silvia Pecere, Francesca DʼAversa, Loris Lopetuso, Maria Assunta Zocco, Maurizia Pompili, Antonio Gasbarrini, 2015.

Roles of Human Gut Microbiota in Liver Cirrhosis Risk: A Two-Sample Mendelian Randomization Study.Ouyang Li, Han Xu, Dayoung Kim, Fan Yang, Zhijun Bao, 2024.

Downloads

Published

2026-06-09

How to Cite

Ismoilova Robiyaxon Shuxrat qizi, & Kenjayev Olimjon Obidjonovich. (2026). THE ROLE OF GUT MICROBIOTA ALTERATIONS IN THE DEVELOPMENT OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS. IQRO , 22(01), 818–821. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/8051